Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30205726 | 0.66 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL29356731 | 0.66 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL26078 | 0.66 | ALDH1A1 (1.00) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| Potassium SCHEMBL29386009 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| Water SCHEMBL28841499 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL19019940 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL141587 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL10354185 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| Water SCHEMBL17558061 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 | |
| SCHEMBL2261751 | 0.64 | ALDH1A1 (0.95) | ALDH1A1LMNAMAPTKDM4EDDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0773281-B1 | Preparations for production of stabilized coolantiubricants | SCHUELKE & MAYR GMBH (DE) | 2005-10-19 | — | — | EP | claimed |
| US-20050065199-A1 | Low-salt or salt-free microbicidal composition based on isothiazolone derivatives and pyrion disulphide | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2005-03-24 | — | — | US | claimed |
| EP-1514473-A1 | Low-salt or salt-free microbicidal composition based on isothiazolone derivatives and pyrion disulphide | Air Liquide Santé (International) (FR) | 2005-03-16 | — | — | EP | claimed |
| EP-0201735-B1 | N-INDOLYLETHYL SULFON AMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1990-09-12 | — | — | EP | claimed |
| EP-0201735-A1 | N-indolylethyl sulfon amides, process for their preparation and their use | BAYER AG (DE) | 1986-11-20 | — | — | EP | claimed |
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | MOLECULAR DEFENSES CORP (US) | 2019-10-10 | — | — | US | disclosed |
| US-9840092-B2 | Image forming apparatus using a pre-processing liquid and a post-processing liquid, and an image forming method using a pre-processing liquid and a post-processing liquid | RICOH COMPANY, LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| WO-2017091737-A1 | PHARMACEUTICAL FORMULATIONS | Molecular Defenses Corporation (US) | 2017-06-01 | — | — | WO | disclosed |
| US-20160136975-A1 | IMAGE FORMING APPARATUS USING A PRE-PROCESSING LIQUID AND A POST-PROCESSING LIQUID, AND IMAGE FORMING METHOD USING A PRE-PROCESSING LIQUID AND A POST-PROCESSING LIQUID | YASU KAZUKI (JP) | 2016-05-19 | — | — | US | disclosed |
| US-9272539-B2 | Image forming apparatus using a pre-processing liquid and a post-processing liquid, and an image forming method using a pre-processing liquid and a post-processing liquid | RICOH COMPANY, LTD. (JP) | 2016-03-01 | — | — | US | disclosed |
| US-8967753-B2 | Image forming apparatus using a pre-processing liquid and drying a printing medium, and image forming method using a pre-processing liquid and drying the printing medium | RICOH COMPANY, LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-20130293617-A1 | IMAGE FORMING APPARATUS USING A PRE-PROCESSING LIQUID AND DRYING A PRINTING MEDIUM, AND IMAGE FORMING METHOD USING A PRE-PROCESSING LIQUID AND DRYING THE PRINTING MEDIUM | SCREEN Holdings Co., Ltd. (JP) | 2013-11-07 | — | — | US | disclosed |
| US-4774240-A | ANTICOAGULANTS, ANTIALLERGENS, ANTIHISTAMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-27 | — | — | US | disclosed |
| EP-0201735-A1 | N-indolylethyl sulfon amides, process for their preparation and their use | BAYER AG (DE) | 1986-11-20 | — | — | EP | disclosed |
| US-4350702-A | 2-SUBSTITUTED BENZISOTHIAZOLONES | BEECHAM GROUP LIMITED (GB) | 1982-09-21 | — | — | US | disclosed |
| US-4243669-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1981-01-06 | — | — | US | disclosed |
| US-4212872-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1980-07-15 | — | — | US | disclosed |
| US-4212979-A | ANTITHROMOGENIC | BEECHAM GROUP LIMITED (GB) | 1980-07-15 | — | — | US | disclosed |
| EP-0001503-A1 | Antithrombotic compositions containing benzisothiazolones | BEECHAM GROUP PLC (GB) | 1979-04-18 | — | — | EP | disclosed |
| US-4113728-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065199-A1 | Low-salt or salt-free microbicidal composition based on isothiazolone derivatives and pyrion disulphide | NOX5, NOX4, NOX1 | ALDH1A1 1188/4885LMNA 4743/4885MAPT 3396/4885 |
| US-20190307726-A1 | PHARMACEUTICAL FORMULATIONS | GSS, GSR, MGST3 | ALDH1A1 2716/4885LMNA 4432/4885MAPT 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.